Davis Capital Management Bristol Myers Squibb CO Transaction History

Davis Capital Management

  • $126 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 05, 2024
SELL
$47.98 - $54.4 $26,484 - $30,028
-552 Reduced 48.68%
582 $30.8 Million
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $237,745 - $283,696
-4,904 Reduced 81.22%
1,134 $58.2 Million
Q1 2020

May 13, 2020
BUY
$46.4 - $67.43 $280,163 - $407,142
6,038 New
6,038 $336,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Davis Capital Management Portfolio

Follow Davis Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Davis Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email